Browsing by Yonsei Author : Lee, Jung-Yun

eperson profile image
Name:
Lee, Jung-Yun [이정윤]
orcid http://orcid.org/0000-0001-7948-1350
Department :
College of Medicine (의과대학) - Dept. of Obstetrics and Gynecology (산부인과학교실)
Scopus ID :
Scopus (56191369600)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 172

This table browses all dspace content
Issue DateTitleJournal Title
2024The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation JOURNAL OF GYNECOLOGIC ONCOLOGY
2024Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian CancerCANCER RESEARCH
2023Initial experience with the da Vinci SP robot-assisted surgical staging of endometrial cancer: a retrospective comparison with conventional laparotomyJOURNAL OF ROBOTIC SURGERY
2023Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian CancerNEW ENGLAND JOURNAL OF MEDICINE
2023Genomic hypomethylation in cell-free DNA predicts responses to checkpoint blockade in lung and breast cancer SCIENTIFIC REPORTS
2023Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trialLANCET ONCOLOGY
2023Secondary cytoreductive surgery with and without hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer GLAND SURGERY
2023Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045INTERNATIONAL JOURNAL OF CANCER
2023Globally shared TCR repertoires within the tumor-infiltrating lymphocytes of patients with metastatic gynecologic cancer SCIENTIFIC REPORTS
2023Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999-2019: Korea Central Cancer Registry Obstetrics & Gynecology Science
2023Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis PLOS ONE
2023Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant ChemotherapyJAMA SURGERY
2023Comparison of Single-Port Laparoscopy with Other Surgical Approaches in Endometrial Cancer Surgical Staging: Propensity-Score-Matched Analysis CANCERS
2023Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancerBRITISH JOURNAL OF CANCER
2023Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D JOURNAL FOR IMMUNOTHERAPY OF CANCER
2023Study protocol for prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC) BMC CANCER
2023Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4 NATURE COMMUNICATIONS
2023Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancerJOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
2023Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With BRCA-Mutated Ovarian CancerCLINICAL CANCER RESEARCH
2023Comparing surgical outcomes of da Vinci SP and da Vinci Xi for endometrial cancer surgical staging in a propensity score-matched study SCIENTIFIC REPORTS
2023RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma JOURNAL OF GYNECOLOGIC ONCOLOGY
2023Phase III MIRASOL (GOG 3045/ENGOT-ov55) study: Initial report of mirvetuximab soravtansine vs. investigator's choice of chemotherapy in platinum-resistant, advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate receptor-alpha expression.JOURNAL OF CLINICAL ONCOLOGY
2023Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) interim results.JOURNAL OF CLINICAL ONCOLOGY
2023Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience JOURNAL OF GYNECOLOGIC ONCOLOGY
2023Sentinel lymph node biopsy in endometrial cancer: The new norm - A multicentre, international experienceSURGICAL ONCOLOGY-OXFORD
2023CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion TherapyCLINICAL CANCER RESEARCH
2023Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer FRONTIERS IN ONCOLOGY
2023BNT162b2 접종과 면역관문억제제 치료 이후 발생한 이상 반응 1예 Korean Journal of Medicine
2023Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer JOURNAL OF GYNECOLOGIC ONCOLOGY
2023Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3 JOURNAL OF GYNECOLOGIC ONCOLOGY
2022USEFULNESS OF PRE-OPERATIVE PET-CT IN PATIENTS WITH ENDOMETRIAL CANCER UNDERGOING SENTINEL LYMPH NODE MAPPING: DO NEGATIVE FINDINGS ON PET-CT NEGATIVITY REALLY INDICATE NODE NEGATIVITY?INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022ROBOTIC-ASSISTED RADICAL VAGINAL TRACHELECTOMYINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022RE-VALIDATION OF CHEMOTHERAPY RESPONSE SCORE (CRS) AS A PROGNOSTIC FACTOR IN OVARIAN CANCER: THE EFFECT OF BEVACIZUMAB AND HIPEC ON SURVIVALINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022PROSPECTIVE MULTI-INSTITUTIONAL PHASE III TRIAL OF STANDARD OF CARE THERAPY WITH OR WITHOUT STEROTACTIC ABLATIVE RADIATION THERAPY FOR RECURRENT OVARIAN CANCER (SABR-ROC, KGOG 3064/KROG 2204)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022PROPENSITY SCORE-MATCHED COMPARISON OF PERIOPERATIVE OUTCOMES USING DA VINCI XI AND SP SURGICAL SYSTEM IN ENDOMETRIAL CANCER SURGICAL STAGINGINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022PREDICTION OF SURGICAL OUTCOMES OF INTERVAL DEBULKING SURGERY (IDS) USING IN ADVANCED OVARIAN CANCER: A NOVEL SCORING SYSTEM USING POST-NEOADJUVANT CHEMOTHERAPY (NAC) COMPUTED TOMOGRAPHY (CT)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022PATIENT-DERIVED ORGANOIDS AS A PRECLINICAL PLATFORM FOR PRECISION MEDICINE IN PATIENTS WITH CERVICAL CANCERINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022OREGOVOMAB AND NON-PLATINUM SINGLE AGENT CHEMOTHERAPY IN PARP INHIBITOR-RESISTANT OVARIAN CANCER PATIENTS NOT CANDIDATE FOR PLATINUM RETREATMENT: A MULTI-COHORT PHASE II STUDY (KGOG 3065/APGOT-OV6)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022LATE-BREAKING ABSTRACT PRESENTATION: COMPARATIVE EFFECTIVENESS OF HIPEC FOLLOWING INTERVAL CYTOREDUCTIVE SURGERY IN PATIENTS WITH ADVANCED-STAGE OVARIAN CANCER UNDERGOING NEOADJUVANT CHEMOTHERAPY: MULTICENTER, PROSPECTIVE, COHORT STUDY (KGOG 3042)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022LAPAROSCOPIC LEFT COMMON ILIAC VEIN INJURY AND REPAIRINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022IMMUNE PROPERTIES OF TUMOR-INFILTRATING LYMPHOCYTES IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMAINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 (HER2) RECEPTOR EXPRESSION AND ITS DYNAMIC CHANGE IN OVARIAN CANCER PATIENTSINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Dynamic changes of peripheral regulatory t cells during parp inhibitor maintenance therapy in patients with ovarian cancerINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trialINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Comprehensive profiling of cervix cancer patients using tumor next-generation sequencing (NGS) and immunohistochemistry (IHC)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022An open label, single arm, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16 or 18 positive recurrent cervical cancer INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Added value of sentinel lymph node biopsy in patients with negative lymph node on triple pre-operative imagesINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer GYNECOLOGIC ONCOLOGY
2022Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?GYNECOLOGIC ONCOLOGY
2022Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer FRONTIERS IN ONCOLOGY

Browse

Links